AKT1 and cancer: As for most malignancies, miR-7 acts as a tumor suppressor by disrupting the PI3K/Akt signaling pathway for cellular proliferation and migration, and its downregulation is also related to decreased effectiveness of cancer therapies (Gajda et al., 2021; Chen et al., 2023).